Raquel Vicente Lidón

8PUBLICATIONS
139CO-AUTHORS
Disease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)Gastroenterology and hepatologyEpidemiological modellingRehabilitation engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 30, 2026
Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry.

|Jan 10, 2026
Clinical, Endoscopic, and Histological Characteristics of Severe Immune Checkpoint Inhibitor-Induced Colitis.

Diego Casas Deza, Cristina Polo Cuadro, Marta Gascón Ruiz

|Jul 30, 2025
Patients Included in Clinical Trials of Biological Drugs for Inflammatory Bowel Disease Do Not Represent the Real-World Population.

Diego Casas Deza, Cristina Larrubia Domínguez, Andrea Pascual Oliver

|Jan 02, 2025
Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence.

Antonio Giordano, Isabel Pérez-Martínez, Javier P Gisbert

|Nov 26, 2024
Persistence, Effectiveness, and Safety of Upadacitinib in Crohn's Disease and Ulcerative Colitis in Real Life: Results From a Spanish Nationwide Study (Ureal Study).

María José García, Yanire Brenes, Miren Vicuña

|Aug 27, 2024
Telemonitoring of Active Inflammatory Bowel Disease Using the App TECCU: Short-Term Results of a Multicenter Trial of GETECCU.

Mariam Aguas, Javier Del Hoyo, Raquel Vicente

Pageof 2

Frequent Collaborators

5 joint publications

Francisco Mesonero Gismero

5 joint publications

Lucía Madero

4 joint publications

María Dolores Martin-Arranz

4 joint publications

María Chaparro